View of the World Well being Group (WHO) headquarters. WHO has issued a medical product alert for 3 contaminated oral liquid medicines recognized in India. |Photograph supplied by: Reuters
The World Well being Group (WHO) has issued a Medical Product Alert for 3 contaminated oral liquid medicines recognized in India and reported to WHO on October 8, 2025. The contaminated oral liquid medicines had been recognized as particular batches of COLDRIF, Respifresh TR, and ReLife manufactured by Sresan Pharmaceutical, Rednex Prescribed drugs, and Form Pharma.
The UN company mentioned India’s Nationwide Regulatory Authority (NRA) has been suggested to think about focused market surveillance, paying specific consideration to casual and unregulated provide chains the place merchandise can flow into undetected. The NRA can be suggested to fastidiously consider the dangers related to oral liquid medicines manufactured on the similar manufacturing web site, particularly these manufactured after December 2024.
“CDSCO knowledgeable WHO that no contaminated medicines had been exported from India and there’s no proof of unlawful export right now,” it mentioned, including that the affected merchandise are oral liquid medicines containing energetic substances generally used to alleviate chilly, flu and cough signs.
Revealing particulars about syrup WHO claimed that the merchandise recognized on this warning don’t meet high quality requirements and specs and are due to this fact thought of substandard.
In a press release, WHO famous that on October 8, 2025, India’s Central Medicine Customary Management Group (CDSCO) reported that no less than three oral liquid medicines comprise diethylene glycol (DEG).
This adopted data recognized by WHO on September 30, 2025, relating to a localized outbreak of acute illness and youngster deaths in India. CDSCO knowledgeable WHO that contaminated merchandise had been reported to have been ingested by affected youngsters.
CDSCO confirmed that the related state authorities have ordered an instantaneous halt to manufacturing on the manufacturing websites concerned and suspended the product’s approval. Moreover, a recall of the contaminated product was initiated by the related state authorities.
“WHO continues to work intently with Indian well being authorities to observe the scenario, establish sources of contamination, and cut back potential public well being dangers.”
The company additional mentioned contaminated merchandise pose a big danger to sufferers and might trigger critical and doubtlessly life-threatening diseases.
Diethylene glycol is poisonous to people and might be deadly if ingested. The contaminated oral liquid medicines talked about on this warning are unsafe and their use, particularly in youngsters, might lead to critical harm or dying. Poisonous results might embody belly ache, vomiting, diarrhea, incapacity to urinate, headache, altered psychological standing, and acute kidney harm that may result in dying. Detecting and eradicating these contaminated merchandise from distribution is crucial to defending sufferers.
It additionally suggested healthcare professionals, regulators and the general public to report detection of those substandard merchandise, prevalence of negative effects or lack of anticipated efficacy to nationwide regulatory authorities or nationwide pharmacovigilance centres.
“We advocate elevated surveillance and surveillance throughout the provide chains of nations and areas prone to be affected by these substandard merchandise. We additionally advocate elevated surveillance of casual/unregulated markets,” it mentioned, including that every one medical merchandise have to be obtained from licensed/licensed suppliers and that data on the manufacture and provide of those merchandise might be shared with WHO through rapidalert@who.int.
